Arm Holdings plc - American Depositary Shares (ARM)

This under-the-radar hospitality stock boasts a Superscore of 79 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

Arm commands smartphone architecture and is moving into AI CPUs; Marvell dominates data center connectivity with 32.6% net margins.

Coupang trades at a fraction of MercadoLibre's sales multiple, but the Latin American fintech giant generates far superior margins and cash flow.

The data center CPU market looks set to explode.

Most investors are looking at something beyond the company's existing EV business.

Neither company needs a data center boom to keep growing. Is that worth owning for the next four years?

Nio's EV deliveries and margins are growing, and it just signed a big partnership. Why is the stock still falling?

Google Cloud isn't the company's main breadwinner yet, but it's definitely moving the needle more than its other businesses.

Investors are underrating the profit potential from one of the fastest-growing large caps globally.

Marvell has widened its revenue lead over the past two years, but ARM's latest quarter shows signs of acceleration that could narrow the gap.

AI is all the rage right now, but the mania could cool off quickly, without warning.

A test equipment giant's robotics arm is chasing physical AI with an early playbook that echoes Amazon's historic rise.

Treasury yields just hit a two-decade high, and I'd still rather risk it and own these three dividend stocks for the next decade.

Qualcomm signed a multiyear patent licensing deal with Huawei covering 5G, compute, and AI, facing FTC review while supporting its data center and robotics diversification strategy.

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on hi...

Invivyd (NASDAQ:IVVD) reported topline results from its Phase III LIBERTY study of VYD2311, an investigational low-dose intramuscular monoclonal antibody designed to prevent COVID-19, and outlined plans to pursue an accelerated-approval pathway with the U.S. Food and Drug Administration. The compan

Ford's commercial division and dealership network contrast sharply with Stellantis's lower debt, but both posted massive losses in 2025.

One specializes in AI connectivity with explosive growth but heavy customer concentration, while the other licenses foundational chip architecture with stable margins.

One is growing faster but trading at a higher valuation while sacrificing near-term profits to capture market share. The other is growing steadily, generating substantial free cash flow, and trading at a more modest premium.

Meta's new Muse agent helped lift CPU stocks, including AMD.

Kodiak Sciences (NASDAQ:KOD) reported that its Phase III DAYBREAK study met primary endpoints for two investigational treatments in treatment-naïve patients with wet age-related macular degeneration, or wet AMD, with both therapies demonstrating statistical equivalence to aflibercept on visual-acuit

What Happened? Shares of semiconductor manufacturer Vishay Intertechnology (NYSE:VSH) jumped 11.1% in the afternoon session after the company released four n...

Two of these stocks are risky bets.

One designs the chips, while the other manufactures the machines that build them. But their valuations tell a starkly different story.

Arm compounds reliably across billions of devices. Credo is posting near-triple-digit growth in AI data center connectivity. The growth gap is significant, and so is the valuation gap.